If you're in London, don't miss CARB-X Executive Director @koutterson.bsky.social’s Fleming Initiative guest lecture at @imperialcollegeldn.bsky.social this Thursday, May 21 at 5:30 PM BST. #IDSky 🧪 🔗 Register here: bit.ly/4cVSEt9

CARB-X@carb-x.bsky.social · 3mo ago

Join CARB-X Executive Director Kevin Outterson for his Fleming Initiative guest lecture at Imperial College London, where he will discuss viewing antibiotics as infrastructure to contextualize their importance in society. #IDSky 🧪 📅 May 21 ⏰ 5:30 – 6:30 PM BST 🔗 bit.ly/4cVSEt9

This is good news for 2040, and only if we adequately support antibiotic R&D. This is early research.. Given a lot of time, excellent science, millions of dollars, and some luck, this might be tested in animals and then people. Otherwise, good work like this may never reach patients.

Geoffrey Lean@geofflean.bsky.social · 4mo ago

Good news. An ancient remedy may work against the modern scourge of antibiotic resistance. Just the latest example of how biodiversity can come to our rescue if we conserve it. phys.org/news/2026-04...

Lord Darzi doing an exceptional job communicating innovation in #AMR

Dr Stephanie Rist, French Minister of Health - describing the economic challenges when antibiotics are thoughtfully protected

Text supporting the One Health model for AMR & humanities and social sciences - #AMR Interesting for the upcoming 5th INAMRSS Research Conference in Munich in coordination with ESMID Global

Kevin Outterson@koutterson.bsky.social · 4mo ago

Excellent One Health model diagram, including AMR and social sciences #AMR

Excellent One Health model diagram, including AMR and social sciences #AMR

The UN will soon unveil a new global science panel on #AMR - what can we do to make it effective and efficient? See the great papers from our conference in Lagos earlier this year: www.cgdev.org/project/buil...

Building the AMR Independent Panel: Lessons and Insights

A collaborative initiative to explore models, lessons, and frameworks to support the Independent Panel on Evidence for Action Against Antimicrobial Resistance

cgdev.org

Are you a researcher working in infectious diseases or #AMR, from a social science discipline (broadly interpreted?). INAMRSS has 3 great opportunities for you! www.globalstrategylab.org/events/open-... Abstract submission open now - move fast!

Open Call for Social Science Presentations On Infectious Diseases - Global Strategy Lab

INAMRSS was founded to advance social science research on infectious diseases, including but not limited to antimicrobial resistance (AMR). In 2026, we are partnering with ESCMID Global (17-21 April i...

globalstrategylab.org

Issac Weldon from Univ Copenhagen describing what #AMR can learn from environmental governance www.youtube.com/watch?v=f4OS... based on our recent article w Kathleen Liddell (Univ Cambridge) in Milbank: pubmed.ncbi.nlm.nih.gov/40876865/

The Role of Environmental Governance in Tackling AMR

YouTube video by Global Strategy Lab

youtube.com

The world needs better science to fight drug-resistant infections. #amr www.cgdev.org/blog/amr-pan...

The AMR Panel Playbook: Eight Lessons for Building an Independent Panel on Antimicrobial Resistance

Antimicrobial resistance (AMR) is one of the greatest health challenges of our time, responsible for 1.14 million deaths a year. Failure to keep resistance in check could lead to $1.7 trillion dollars...

cgdev.org

How should the new Independent Panel on Evidence for Action on #AMR be set up? We gathered scientists and stakeholders - mainly from Africa - to think this through in Lagos, Nigeria. Pre-print now available: verixiv.org/articles/2-2...

Who should pay for #AMR innovation? www.sciencedirect.com/science/arti... @akesselheim.bsky.social

Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27

Antimicrobial resistance (AMR) poses an important global health challenge, including insufficient investment in research and development. This study q…

sciencedirect.com

New funding opportunity opened today for Gram-negative antibacterial discovery (as late as LO) in therapeutics! gcgh.grandchallenges.org/challenge/in...

Welcome

Marc Mendelson@southafricanasp.bsky.social · last yr.

Looking forward to a $🚀-free, Orange-free experience on Bluesky 🙂 #AMR #InfectiousDiseases #vaccination #WASH #Pandemics #GlobalHealth #Health

This law student note presumes that important zoonotic jumps from animals to humans occur in the USA, leading to a recommendation to more tightly regulate live animal importation. For most salient examples, such as COVID and HIV/AIDS, zoonotic transmission was outside the USA.

Infectious Diseases@infectiousdz.bsky.social · 2y ago

The Harvard Law Review on "The Import of Zoonotic Diseases" in the US. A timely review as climate and environmental changes, extractive and agricultural industries, and increasing human mobility heighten our risk of exposure to zoonotic infections. harvardlawreview.org/print/vol-13...

Which lessons can be learned from prior international science panels? How can this help the new Independent Panel on Evidence for Action on AMR? www.cgdev.org/blog/chartin...

Charting the Path to Tackle AMR: How to Create an Inclusive and Impactful Independent Panel

In 2021 alone, AMR killed an estimated 1.14 million people annually—and if countries stick to a business-as-usual approach, it could claim 39 million lives between 2025 and 2050. Beyond the human toll...

cgdev.org

@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.

@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.

Dr Sonia Lewycka on equity discourse in AMR. Most AMR deaths are in lower income settings, so solutions must center equity. (Un)intended Consequences conf @ British Academy.

Nice way to transform Reviewer 2 comments into a paper!

Christian Landry@christianlandry.bsky.social · 2y ago

While writing papers and grants, we received many comments on the role of CNVs in antifungal resistance. We thought we should formally assess how important they are. Here is what we found. #AMR #fungi #evolution rdcu.be/d5rbN

I also have concerns about the equities of this system

Jeremy Berg@jeremymberg.bsky.social · 2y ago

My main concerns relate to the question of age of retirement. I have thought about a 5 year rolling contract system whereby a faculty member would have 5 years of job security as long as they were performing at a reasonable level. This addresses the problem of truly non-contributory senior faculty.

Academic Twitter found a new home. More Bluetorials, please. Any regrets from how the tenure system operates?

Jeremy Berg@jeremymberg.bsky.social · 2y ago

Bluetorial: Adventures with tenure-Part 2 My experiences on the Johns Hopkins School of Medicine Professorial Promotions Committee with some thoughts about scholarship vs fund raising success, team science, hyperproductivity, and the age distribution of the professoriate.

Do we have an AMR group?

Anita Williams@catanita.bsky.social · 2y ago

Hey #AMR and #MicroSky people, @bonniehyatt.bsky.social is here! Bonnie is a great PhD student at @thekidsau.bsky.social with @tbarnett.bsky.social, and recently won a WCVID seed grant to investigate the microbiome-dependent antibiotic resistance in Strep A.

Access to essential medicines is not improving over the past 4 decades with existing tools. "The gap between richer (high- and upper-middle-income) and poorer (lower-middle- and low-income) countries remained largely unchanged over time." www.healthaffairs.org/doi/epdf/10....

Most cervical cancer deaths are in lower-income settings worldwide; rollout of the vaccines there has been painfully slower than high-income countries. Bring this good thing to more people.

John P de New 🇦🇺🇨🇦🇩🇪🇪🇺@denewjohn.bsky.social · 2y ago

HPV vaccines work.

15 years data on infections from the US VA: www.thelancet.com/journals/lan... My 3 takeaways: (1) Infection prevention and control works; (2) We still need better antibiotics; and (3) the choice of the denominator in such studies should be carefully made www.thelancet.com/journals/lan...

Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)

Significant reductions in methicillin resistance in S aureus, vancomycin-resistant E faecium, and fluoroquinolone resistance across multiple pathogens suggest that control efforts have had an effect on resistance. The rise in extended-spectrum β-lactamases-producing Enterobacterales and recent surge in hospital-associated infections emphasise the need for ongoing surveillance and interventions. Our study highlights how coupling the analysis of phenotypic incidence with resistance proportion can enhance interpretation of antimicrobial resistance data.

thelancet.com

Bacteria adapt to take advantage of human weaknesses and situations, including war. We should not be surprised that the bacteria rule the battlefield. www.nytimes.com/2024/11/26/m...

Modern Warfare Is Breeding Deadly Superbugs. Why?

Researchers are trying to understand why resistant pathogens are so prevalent in the war-torn nations of the Middle East.

nytimes.com

Research is of limited use unless communicated - thanks for this 1 pager

Dr Abeba Birhane@abeba.blacksky.app · 2y ago

i wrote this a while back but i think it still holds

Analysis like this systematic review from 5 years ago is needed to move AMR policy forward in the era of an Independent Panel on Evidence For Action on AMR. #IPEA-AMR Here, a careful critique of methodology choices in studies reporting the economic costs of AMR. link.springer.com/article/10.1...

Using the best available data to estimate the cost of antimicrobial resistance: a systematic review - Antimicrobial Resistance & Infection Control

Background Valuation of the economic cost of antimicrobial resistance (AMR) is important for decision making and should be estimated accurately. Highly variable or erroneous estimates may alarm policy...

link.springer.com

When azithromycin is overused in high-income countries, no one tries to stop life-saving treatments. 1/2 www.nejm.org/doi/full/10....

Azithromycin to Reduce Mortality | NEJM

To the Editor: The AVENIR (Azithromycine pour la Vie des Enfants au Niger: Implementation et Recherche) trial reported by O’Brien et al. (Aug. 22/29 issue)1 shows the mortality benefit of mass dist...

nejm.org